Although EMPEROR-R enrolled patients with and without type 2 diabetes, the primary outcome of the trial (a composite of CV death and hospitalization for HF) was almost identical in both groups, suggesting that the different population didnt affect the results, at least for the primary outcome
Weight loss parity with AOM augmentation Clinical evidence demonstrates that early non-responders to behavioral therapy can achieve comparable weight outcomes to initial strong responders when provided with anti-obesity medication (AOM)
Conclusion: Managing Sulfur Burps Sulfur burps can be an unexpected digestive effect of Ozempic and other GLP-1 medications, but they are often manageable with the right approach
[1] [5] Currently available GLP-1 medications in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GLP-1/GIP receptor agonist
Patients seeking GLP-1 therapy should consult their healthcare provider about FDA-approved injectable or oral formulations and proper administration techniques for those products
Doctor-Led Care Conveniently Online Clear and Predictable Pricing Frequently asked questions What Are GLP-1 medications
